Canopy Growth vs SNDL
CGC and SNDL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CGC and SNDL compare
Canopy Growth grew revenue faster over the last twelve months (6.8% versus 2.8% for SNDL).
SNDL keeps more of each dollar of sales as profit, with a net margin of −1.7% compared with −79.2% at Canopy Growth.
SNDL scores higher on the StockData Score (5 against 3 for Canopy Growth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CGC | SNDL |
|---|---|---|
| Size and price | ||
| Share price | $0.531 | $1.34 |
| Change, 1 year | −50.3% | −20.2% |
| Change, 5 years | −99.5% | −79.5% |
| Beta (5Y) | 1.23 | 0.39 |
| Employees | 1,128 | 2,607 |
| StockData Score | ||
| Total score | 3 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 6.8% (better) | 2.8% |
| Revenue growth, 5Y average | −12.2% | 73.1% (better) |
| Profitability | ||
| Gross margin | 25.2% | 27.3% (better) |
| Operating margin | −54.9% | −0.67% (better) |
| Net margin | −79.2% | −1.7% (better) |
| FCF margin | −28.3% | 6.1% (better) |
| Return on equity | – | −1.4% |
| Return on invested capital | – | −0.57% |
| Financial health | ||
| Interest coverage | −3.9× | −0.9× (better) |
| Current ratio | 3.04 | 4.88 (better) |
| Piotroski F-score | 5 | 7 (better) |
| Ownership | ||
| Held by institutions | 6.9% | 18.6% |
| Held by insiders | 1.0% | 0.00% |
| Insider net buying, 12 months | −$393K | – |
Go deeper
- CGC stock overview
- CGC income statement
- CGC valuation and score
- SNDL stock overview
- SNDL income statement
- SNDL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.